ALK and non-small cell lung carcinoma: This study aimed to investigate the incidence, risk factors, and impact of VTE on overall survival.<h4>Methods</h4>We retrospectively analyzed patients with advanced ALK-positive NSCLC treated at Karolinska University Hospital from 2009 to 2021.